Noninvasive sialic acid detection at cell membrane by using phenylboronic acid modified self-assembled monolayer gold electrode.

Alternations of sialic acid (SA) content on cell surface glycan chains have been implicated in numerous normal and pathological processes including developments, differentiations, and tumor metastasis. Overexpressions of SA have been implicated in the malignant and metastatic phenotypes for many different types of cancers, while decreased SA expression has also been identified in erythrocytes of diabetic mellitus. Techniques to conveniently monitor cell surface SA would therefore have great relevance to cytology. Preexisting methodologies to quantify SA, however, involve multiple enzymatic, dye-labeling, and lethal procedures, which are costly and time-consuming. Here we developed a potentiometric SA detection using a phenylboronic acid (PBA) compound integrated into the form of a self-assembled monolayer (SAM) onto a field effect transistor (FET) extended gold gate electrode. Due to selective binding between undisassociated PBA and SA at pH 7.4 among other glycan chain constituent monosaccharides, we found that carboxyl anions of SA were exclusively detectable as the change in threshold voltage (V(T)) of the PBA-modified FET. The technique was applied to analyses of altered SA expressions on rabbit erythrocyte as a model for diabetes. Comparative SA expression analyses for each healthy and diseased model revealed that the disease could be feasibly diagnosed simply by placing the known-count cell suspensions onto the device without any labeling and enzymatic procedures. Such a technique may also provide a quantitative adjunct to histological evaluation of tumor malignancy and metastatic potential during intra- and postoperative diagnoses. Also advantageously, a technique herein described is all within a CMOS (Complementary Metal Oxide Semiconductor) compatible format thus promising for highly efficient and low cost manufacturing with readiness of downsizing and integration by virtue of advanced semiconductor processing technologies.

[1]  V. Haldankar,et al.  RBC membrane composition in insulin dependent diabetes mellitus in context of oxidative stress , 2008, Indian Journal of Clinical Biochemistry.

[2]  Shigehiro Takahashi,et al.  Electrochemical Determination of L-Lactate Using Phenylboronic Acid Monolayer-Modified Electrodes , 2008 .

[3]  D. Hall,et al.  An improved class of sugar-binding boronic acids, soluble and capable of complexing glycosides in neutral water. , 2006, Journal of the American Chemical Society.

[4]  J. Paulson,et al.  Glycomics: an integrated systems approach to structure-function relationships of glycans , 2005, Nature Methods.

[5]  Joop A. Peters,et al.  Molecular recognition of sialic acid end groups by phenylboronates. , 2005, Chemistry.

[6]  Joop A. Peters,et al.  Towards targeted MRI: new MRI contrast agents for sialic acid detection. , 2004, Chemistry.

[7]  K. Kataoka,et al.  Glucose-responsive polymer bearing a novel phenylborate derivative as a glucose-sensing moiety operating at physiological pH conditions. , 2003, Biomacromolecules.

[8]  Teruo Okano,et al.  Anomalous binding profile of phenylboronic acid with N-acetylneuraminic acid (Neu5Ac) in aqueous solution with varying pH. , 2003, Journal of the American Chemical Society.

[9]  L. Mazzanti,et al.  Acidic and neutral sialidase in the erythrocyte membrane of type 2 diabetic patients. , 2002 .

[10]  T. Okano,et al.  Totally synthetic polymer with lectin-like function: induction of killer cells by the copolymer of 3-acrylamidophenylboronic acid with N,N-dimethylacrylamide. , 2001, Biotechnology and bioengineering.

[11]  M. Fukuda Possible roles of tumor-associated carbohydrate antigens. , 1996, Cancer research.

[12]  M W Rampling,et al.  Decrease in erythrocyte glycophorin sialic acid content is associated with increased erythrocyte aggregation in human diabetes. , 1992, Clinical science.

[13]  A. Passaniti,et al.  Cell surface sialylation and tumor metastasis. Metastatic potential of B16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharide structures. , 1988, The Journal of biological chemistry.

[14]  S. N. CHARI,et al.  Sialic Acid Content and Sialidase Activity of Polymorphonuclear Leucocytes in Diabetes Mellitus , 1984, The American journal of the medical sciences.

[15]  Z. Pavelic,et al.  A correlation between cell surface sialyltransferase, sialic acid, and glycosidase activities and the implantability of B16 murine melanoma. , 1981, Cancer research.

[16]  C. Bucana,et al.  Cell surface properties of B16 melanoma variants with differing metastatic potential. , 1980, Cancer research.

[17]  L. Gerbaut,et al.  Simultaneous determination of sialic acid and protein in erythrocyte membrane from diabetic patients. , 1978, Clinical chemistry.

[18]  S. Aronoff,et al.  Complexation of D-glucose with borate , 1975 .

[19]  John O. Edwards,et al.  Polyol Complexes and Structure of the Benzeneboronate Ion , 1959 .

[20]  Joop A. Peters,et al.  Phenylboronate 160Tb complexes for molecular recognition of glycoproteins expressed on tumor cells. , 2007, Contrast media & molecular imaging.

[21]  Carolyn R. Bertozzi,et al.  Chemical Glycobiology , 2001, Science.